|
AU6309698A
(en)
*
|
1997-03-12 |
1998-09-29 |
Banyu Pharmaceutical Co., Ltd. |
Drugs containing aminopyridine derivatives as the active ingredient
|
|
GB9709815D0
(en)
*
|
1997-05-14 |
1997-07-09 |
Merck Sharp & Dohme |
Therapeutic method
|
|
AU744297B2
(en)
*
|
1997-07-03 |
2002-02-21 |
Neurogen Corporation |
Certain diarylimidazole derivatives; a new class of NPY specific ligands
|
|
AU8914798A
(en)
*
|
1997-08-25 |
1999-03-16 |
Bayer Corporation |
Heterocyclic ketones as npy y5 antagonists
|
|
WO1999027965A1
(en)
*
|
1997-11-28 |
1999-06-10 |
Banyu Pharmaceutical Co., Ltd. |
Antihyperlipemic agents
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
US6140354A
(en)
*
|
1998-04-29 |
2000-10-31 |
Ortho-Mcneil Pharmaceutical, Inc. |
N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
|
|
US6191160B1
(en)
|
1998-11-10 |
2001-02-20 |
Merck & Co., Inc. |
Spiro-indolines as Y5 receptor antagonists
|
|
US6407120B1
(en)
|
1999-02-18 |
2002-06-18 |
Pfizer Inc. |
Neuropeptide Y antagonists
|
|
EP1184373A4
(en)
|
1999-04-20 |
2004-10-20 |
Meiji Seika Kaisha |
Tricyclic compounds
|
|
EP1816127A1
(en)
|
1999-04-22 |
2007-08-08 |
H. Lundbeck A/S |
Triazine derivatives for use as selective npy (y5) antagonists
|
|
US6989379B1
(en)
|
1999-04-22 |
2006-01-24 |
H. Lundbick A/S |
Selective NPY (Y5) antagonists
|
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
|
US6218408B1
(en)
|
1999-06-30 |
2001-04-17 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
|
HK1041263A1
(en)
*
|
1999-05-05 |
2002-07-05 |
Ortho-Mcneil Pharmaceutical, Inc. |
3a, 4,5,9b-tetrahydro-1h-benz[e] indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders
|
|
US6841552B1
(en)
|
1999-05-05 |
2005-01-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders
|
|
US6214853B1
(en)
|
1999-06-30 |
2001-04-10 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
|
US7273880B2
(en)
|
1999-06-30 |
2007-09-25 |
H. Lunbeck A/S |
Selective NPY (Y5) antagonists
|
|
US6225330B1
(en)
|
1999-06-30 |
2001-05-01 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (tricyclics)
|
|
US6222040B1
(en)
|
1999-06-30 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (tricyclics)
|
|
AU1201401A
(en)
|
1999-10-15 |
2001-04-30 |
Du Pont Pharmaceuticals Company |
Benzylcycloalkyl amines as modulators of chemokine receptor activity
|
|
US6291499B1
(en)
*
|
1999-10-29 |
2001-09-18 |
Merck & Co., Inc. |
2-cyclohexyl benzimidazole NMDA/NR2B antagonists
|
|
ATE466573T1
(en)
*
|
1999-11-26 |
2010-05-15 |
Shionogi & Co |
NPYY5 ANTAGONISTS
|
|
WO2002006276A1
(en)
|
2000-07-13 |
2002-01-24 |
Eli Lilly And Company |
Beta3 adrenergic agonists
|
|
US7544690B2
(en)
|
2001-10-01 |
2009-06-09 |
Taisho Pharmaceutical Co., Ltd. |
MCH receptor antagonists
|
|
CA2403307A1
(en)
*
|
2001-10-23 |
2003-04-23 |
Neurogen Corporation |
Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
|
|
ES2193875B2
(en)
|
2002-04-09 |
2005-03-01 |
Laboratorios Del Dr. Esteve, S.A. |
DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS.
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
EP1398032A1
(en)
*
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
EP1407774A1
(en)
*
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
US7589207B2
(en)
|
2002-12-13 |
2009-09-15 |
Smithkline Beecham Corporation |
Cyclohexyl compounds as CCR5 antagonists
|
|
AU2003297460A1
(en)
*
|
2002-12-19 |
2004-07-14 |
Scios, Inc. |
TREATMENT OF OBESITY AND ASSOCIATED CONDITIONS WITH TGF-Beta INHIBITORS
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
JP2006522109A
(en)
*
|
2003-03-31 |
2006-09-28 |
大正製薬株式会社 |
Novel quinazoline derivatives and therapeutic methods related to their use
|
|
JP2004315511A
(en)
*
|
2003-03-31 |
2004-11-11 |
Taisho Pharmaceut Co Ltd |
MCH receptor antagonist
|
|
EP1620091B1
(en)
|
2003-05-05 |
2010-03-31 |
Probiodrug AG |
Inhibitors of glutaminyl cyclase
|
|
ATE440825T1
(en)
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
PYRIMIDINE DERIVATIVES FOR USE AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
|
|
US8309562B2
(en)
|
2003-07-03 |
2012-11-13 |
Myrexis, Inc. |
Compounds and therapeutical use thereof
|
|
AU2004253967B2
(en)
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
|
ES2222833B1
(en)
|
2003-07-30 |
2006-03-01 |
Laboratorios Del Dr. Esteve, S.A. |
1,4-DISPOSED PIPERIDINIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICINES.
|
|
CA2551037A1
(en)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
Novel piperidine derivative
|
|
JP2007510629A
(en)
|
2003-10-22 |
2007-04-26 |
イーライ リリー アンド カンパニー |
Novel MCH receptor antagonist
|
|
AU2004290499C1
(en)
|
2003-11-03 |
2011-02-24 |
Probiodrug Ag |
Combinations useful for the treatment of neuronal disorders
|
|
GB0400193D0
(en)
*
|
2004-01-07 |
2004-02-11 |
Astrazeneca Ab |
Therapeutic agents
|
|
CA2554809C
(en)
|
2004-02-05 |
2014-04-29 |
Probiodrug Ag |
Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase
|
|
CA2558915A1
(en)
*
|
2004-03-30 |
2005-10-13 |
Taisho Pharmaceutical Co., Ltd. |
Pyrimidine derivatives and methods of treatment related to the use thereof
|
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING MEN WITH METABOLIC AND ANTHROPOMETRIC DISORDERS
|
|
JP2008505910A
(en)
*
|
2004-07-08 |
2008-02-28 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
Pyrimidine derivatives useful as inhibitors of PKC-theta
|
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
KR101123549B1
(en)
|
2004-11-01 |
2012-04-18 |
아밀린 파마슈티칼스, 인크. |
Treatment of obesity and related disorders
|
|
US8258145B2
(en)
|
2005-01-03 |
2012-09-04 |
Myrexis, Inc. |
Method of treating brain cancer
|
|
EP1833482A4
(en)
|
2005-01-03 |
2011-02-16 |
Myriad Genetics Inc |
NITROGEN BICYCLIC COMPOUNDS AND THERAPEUTIC USE THEREOF
|
|
US20090286723A1
(en)
|
2005-02-11 |
2009-11-19 |
Amylin Pharmaceuticals, Inc. |
Hybrid Polypeptides with Selectable Properties
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
BRPI0610580B8
(en)
|
2005-05-30 |
2021-05-25 |
Banyu Pharma Co Ltd |
piperidine derivative compound
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
US20060281712A1
(en)
|
2005-06-14 |
2006-12-14 |
Chi-Feng Yen |
Pyrimidine compounds
|
|
US20100216758A1
(en)
|
2005-08-10 |
2010-08-26 |
Makoto Ando |
Pyridone Compounds
|
|
EP2330125A3
(en)
|
2005-08-11 |
2012-12-12 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
|
WO2007024004A1
(en)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
CA2621470A1
(en)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
Bicyclic aromatic substituted pyridone derivative
|
|
CN101277960A
(en)
|
2005-09-29 |
2008-10-01 |
默克公司 |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
US20080255084A1
(en)
|
2005-10-21 |
2008-10-16 |
Randy Lee Webb |
Combination of Organic Compounds
|
|
CA2627139A1
(en)
|
2005-10-27 |
2007-05-03 |
Banyu Pharmaceutical Co., Ltd. |
Novel benzoxathiin derivative
|
|
BRPI0618354B8
(en)
|
2005-11-10 |
2021-05-25 |
Banyu Pharma Co Ltd |
compound and its use, pharmaceutical composition, preventive or medicine
|
|
BRPI0710950A2
(en)
|
2006-04-28 |
2012-06-26 |
Shionogi & Co |
amine derivative having npi 53 y5 receptor antagonistic activity a61p 3/04 a61p 9/04 a61p 9/12 a61p 15/00 a61p 25/08 a61p 25/20 a61p 25/24 a61p 43/00 c07c 311/07 c07c 317 / 36 c07d 207/325 c07d 211/14 c07d 213/38 c07d 213/74 c07d 213/82 c07d 215/38 c07d 217/04 c07d 217/14 c07d 217/22 c07d 219/10 c07d 231/38 c07d 233/61 c07d 235/30 c07d 237/20 c07d 237/22 c07d 237/34 c07d 239/42 c07d 241/20 c07d 261/14 c07d 261/20 c07d 263/58 c07d 265/30 c07d 265/36 c07d 267/14 c07d 275 / 02 c07d 277/28 c07d 277/62 c07d 277/82 c07d 295/12 c07d 295/18 c07d 333/36 c07d 333/40 c07d 333/66 c07d 333/72 c07d 403/04 c07d 409/04 c07d 413/04 c07d 417/12 c07d 498/04 c07d 513/04
|
|
EP2698157B1
(en)
|
2006-09-22 |
2015-05-20 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
WO2008047544A1
(en)
|
2006-09-28 |
2008-04-24 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
JP5379692B2
(en)
|
2006-11-09 |
2013-12-25 |
プロビオドルグ エージー |
3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcers, cancer and other diseases
|
|
DK2091948T3
(en)
|
2006-11-30 |
2012-07-23 |
Probiodrug Ag |
Novel inhibitors of glutaminyl cyclase
|
|
AU2008220785B2
(en)
|
2007-03-01 |
2013-02-21 |
Vivoryon Therapeutics N.V. |
New use of glutaminyl cyclase inhibitors
|
|
WO2008120653A1
(en)
|
2007-04-02 |
2008-10-09 |
Banyu Pharmaceutical Co., Ltd. |
Indoledione derivative
|
|
US9656991B2
(en)
|
2007-04-18 |
2017-05-23 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
ES2559319T3
(en)
|
2007-06-04 |
2016-02-11 |
Synergy Pharmaceuticals Inc. |
Guanylate cliclas agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
SA08290668B1
(en)
|
2007-10-25 |
2012-02-12 |
شيونوجي آند كو.، ليمتد |
Amine Derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
|
|
PE20091309A1
(en)
*
|
2007-12-21 |
2009-09-30 |
Astrazeneca Ab |
CYCLOHEXYL DERIVATIVES AS ACETYL COENZYME CARBOXYLASE INHIBITORS
|
|
US20110015181A1
(en)
|
2008-03-06 |
2011-01-20 |
Makoto Ando |
Alkylaminopyridine derivative
|
|
EP2272841A1
(en)
|
2008-03-28 |
2011-01-12 |
Banyu Pharmaceutical Co., Ltd. |
Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
|
|
US8372849B2
(en)
|
2008-04-21 |
2013-02-12 |
Taigen Biotechnology Co., Ltd. |
Heterocyclic compounds
|
|
CL2009000904A1
(en)
|
2008-04-21 |
2010-04-30 |
Shionogi & Co |
Compounds derived from cyclohexyl sulfonamides having antagonist activity at the npy y5 receptor, pharmaceutical composition and pharmaceutical formulation comprising them.
|
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
US20110124674A1
(en)
|
2008-07-30 |
2011-05-26 |
Hiroyuki Kishino |
5/5-or 5/6-membered condensed ring cycloalkylamine derivative
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
JP5635991B2
(en)
|
2008-10-30 |
2014-12-03 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Isonicotinamide orexin receptor antagonist
|
|
CA2741672A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
TW201021855A
(en)
|
2008-11-13 |
2010-06-16 |
Taigen Biotechnology Co Ltd |
Lyophilization formulation
|
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
EP2379562A1
(en)
|
2008-12-16 |
2011-10-26 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
|
JP5685181B2
(en)
*
|
2009-03-05 |
2015-03-18 |
塩野義製薬株式会社 |
Cyclohexane derivative having NPYY5 receptor antagonistic action
|
|
US8227618B2
(en)
|
2009-04-23 |
2012-07-24 |
Shionogi & Co., Ltd. |
Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
|
|
LT3575288T
(en)
*
|
2009-09-03 |
2021-12-10 |
Bristol-Myers Squibb Company |
QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
|
|
EP2475428B1
(en)
|
2009-09-11 |
2015-07-01 |
Probiodrug AG |
Heterocylcic derivatives as inhibitors of glutaminyl cyclase
|
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
JP6026284B2
(en)
|
2010-03-03 |
2016-11-16 |
プロビオドルグ エージー |
Inhibitors of glutaminyl cyclase
|
|
EA022420B1
(en)
|
2010-03-10 |
2015-12-30 |
Пробиодруг Аг |
Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
|
|
WO2011131748A2
(en)
|
2010-04-21 |
2011-10-27 |
Probiodrug Ag |
Novel inhibitors
|
|
JP5812500B2
(en)
|
2010-04-30 |
2015-11-17 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Novel β3 adrenergic receptor agonist
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
EA201690035A1
(en)
|
2011-02-25 |
2016-05-31 |
Мерк Шарп Энд Домэ Корп. |
NEW CYCLIC DERIVATIVES OF AZABENZIMIDAZOLE, USED AS ANTI-DIABETIC AGENTS
|
|
ES2570167T3
(en)
|
2011-03-16 |
2016-05-17 |
Probiodrug Ag |
Benzimidazole derivatives as glutaminyl cyclase inhibitors
|
|
AR088352A1
(en)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE
|
|
JP2015525782A
(en)
|
2012-08-02 |
2015-09-07 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Antidiabetic tricyclic compounds
|
|
WO2014130608A1
(en)
|
2013-02-22 |
2014-08-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
EA201592263A1
(en)
|
2013-06-05 |
2016-05-31 |
Синерджи Фармасьютикалз, Инк. |
ULTRASCULAR AGONISTS OF GUANYLACYCLASE C, METHOD OF THEIR RECEIVING AND USING
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
KR102431436B1
(en)
|
2014-08-29 |
2022-08-10 |
테스 파마 에스.알.엘. |
INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
|
|
US20180134667A1
(en)
|
2016-10-14 |
2018-05-17 |
TES Pharma S.r.I. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
ES2812698T3
(en)
|
2017-09-29 |
2021-03-18 |
Probiodrug Ag |
Glutaminyl cyclase inhibitors
|
|
WO2020104456A1
(en)
|
2018-11-20 |
2020-05-28 |
Tes Pharma S.R.L |
INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
|
|
WO2020113094A1
(en)
|
2018-11-30 |
2020-06-04 |
Nuvation Bio Inc. |
Pyrrole and pyrazole compounds and methods of use thereof
|
|
WO2020167701A1
(en)
|
2019-02-13 |
2020-08-20 |
Merck Sharp & Dohme Corp. |
Pyrrolidine orexin receptor agonists
|
|
TW202045476A
(en)
|
2019-02-13 |
2020-12-16 |
美商默沙東藥廠 |
5-alkyl pyrrolidine orexin receptor agonists
|
|
WO2021007487A1
(en)
|
2019-07-11 |
2021-01-14 |
Praxis Precision Medicines, Inc. |
Formulations of t-type calcium channel modulators and methods of use thereof
|
|
US12312332B2
(en)
|
2019-08-08 |
2025-05-27 |
Merck Sharp & Dohme Llc |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
|
TW202227417A
(en)
|
2020-08-18 |
2022-07-16 |
美商默沙東藥廠 |
Bicycloheptane pyrrolidine orexin receptor agonists
|
|
CN114315802B
(en)
*
|
2021-12-14 |
2023-06-16 |
西安医学院 |
Quinazoline nitrogen-containing heterocyclic derivative, preparation method and application
|
|
US20250051290A1
(en)
*
|
2021-12-24 |
2025-02-13 |
Ajou University Industry-Academic Cooperation Foundation |
Novel compound for improving sleep or use thereof
|